Agenix (AGX) Short Interest
Agenix (ASX:AGX) had 0.00% of shares reported as short positions as of 11 July 2016, representing 90 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Agenix
Agenix is a biotechnology company focused on developing innovative pharmaceuticals for unmet medical needs. The company leverages cutting-edge technology to create unique therapeutic solutions, aiming to improve patient outcomes and establish a strong presence in the healthcare market.
Short position
Agenix (ASX:AGX) has 0.00% of its shares on issue reported as short positions as of 11 July 2016, or about 90 shares. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AGX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Agenix
Be the first to discuss AGX
Start a research thread or post the first pulse update